Pulling SEC filings + quote and writing the call…
TBPH
Theravance Biopharma, Inc.
Next earnings Aug 10, 2026 · consensus $0.05 EPS, $22.2M rev
Last earnings +0.5% on 2026-05-07
$16.64
▲ +0.36%$16.58▲ +54.23%
over 1Y
L $10.57EODHDH $20.74
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today+0.4%
1W+0.5%
1M+2.0%
3M+18.3%
YTD-8.7%
1Y+54.2%
Buy
Conviction
Horizon
Medium (3–12mo)
Street · 12 analysts
Buy
Revenue grew 66.9% YoY.
The read
Quality fundamentals and an attractive price line up (~370% below fair value) — the rarer case where both the business and the entry look good.
Sources: SEC EDGAR (CIK 0001583107, latest 10-Q filed 2026-05-07) · EODHD · as of 6/22/2026, 2:26:47 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.